# | Title | Journal | Year | Citations |
---|
1 | Nitric Oxide as a Signaling Molecule in the Vascular System: An Overview | Journal of Cardiovascular Pharmacology | 1999 | 692 |
2 | The Importance of the Hyperpolarizing Mechanism Increases as the Vessel Size Decreases in Endothelium-Dependent Relaxations in Rat Mesenteric Circulation | Journal of Cardiovascular Pharmacology | 1996 | 603 |
3 | Impaired Endothelium-Dependent Relaxation in Rabbit Pulmonary Artery After Subarachnoid Hemorrhage | Journal of Cardiovascular Pharmacology | 1996 | 526 |
4 | Energy Metabolic Phenotype of the Cardiomyocyte During Development, Differentiation, and Postnatal Maturation | Journal of Cardiovascular Pharmacology | 2010 | 512 |
5 | The Role of Endothelium in Cardiovascular Homeostasis and Diseases | Journal of Cardiovascular Pharmacology | 1993 | 445 |
6 | The Biochemical Pathways of Nitric Oxide Formation from Nitrovasodilators | Journal of Cardiovascular Pharmacology | 1991 | 436 |
7 | Effect of Cilostazol, a Cyclic AMP Phosphodiesterase Inhibitor, on the Proliferation of Rat Aortic Smooth Muscle Cells in Culture | Journal of Cardiovascular Pharmacology | 1992 | 434 |
8 | The Pharmacology of a β2-Selective Adrenoceptor Antagonist (ICI 118,551) | Journal of Cardiovascular Pharmacology | 1983 | 424 |
9 | Endogenous Dimethylarginine as an Inhibitor of Nitric Oxide Synthesis | Journal of Cardiovascular Pharmacology | 1992 | 404 |
10 | Reduced Urinary Excretion of Nitric Oxide Metabolites and Increased Plasma Levels of Asymmetric Dimethylarginine in Men with Essential Hypertension | Journal of Cardiovascular Pharmacology | 1999 | 375 |
11 | Fibroblasts and Myofibroblasts: What Are We Talking About? | Journal of Cardiovascular Pharmacology | 2011 | 372 |
12 | Flow-Dependent, Endothelium-Mediated Dilation of Epicardial Coronary Arteries in Conscious Dogs | Journal of Cardiovascular Pharmacology | 1984 | 361 |
13 | High-carbohydrate High-fat Diet–induced Metabolic Syndrome and Cardiovascular Remodeling in Rats | Journal of Cardiovascular Pharmacology | 2011 | 348 |
14 | Rho Kinase (ROCK) Inhibitors | Journal of Cardiovascular Pharmacology | 2007 | 344 |
15 | Cytokines Regulate Vascular Functions Related to Stability of the Atherosclerotic Plaque | Journal of Cardiovascular Pharmacology | 1995 | 301 |
16 | On the Mechanism of NO Release from Sydnonimines | Journal of Cardiovascular Pharmacology | 1989 | 299 |
17 | Fibrosis and Cardiac Arrhythmias | Journal of Cardiovascular Pharmacology | 2011 | 291 |
18 | The Role of Low-Dose Diuretics in Essential Hypertension | Journal of Cardiovascular Pharmacology | 1993 | 289 |
19 | Endothelial Cells as Mediators of Vasodilation of Arteries | Journal of Cardiovascular Pharmacology | 1984 | 280 |
20 | Endothelin-1 and Endothelin-3 Release EDRF from Isolated Perfused Arterial Vessels of the Rat and Rabbit | Journal of Cardiovascular Pharmacology | 1989 | 276 |
21 | COX-2 Inhibitors and Cardiovascular Risk | Journal of Cardiovascular Pharmacology | 2007 | 276 |
22 | The Effect of Flavanol-rich Cocoa on the fMRI Response to a Cognitive Task in Healthy Young People | Journal of Cardiovascular Pharmacology | 2006 | 269 |
23 | Finerenone, a Novel Selective Nonsteroidal Mineralocorticoid Receptor Antagonist Protects From Rat Cardiorenal Injury | Journal of Cardiovascular Pharmacology | 2014 | 265 |
24 | Rho-kinase as a Novel Therapeutic Target in Treatment of Cardiovascular Diseases | Journal of Cardiovascular Pharmacology | 2002 | 259 |
25 | Varying Extracellular [K+] | Journal of Cardiovascular Pharmacology | 1993 | 252 |
26 | Remodeling of Developing and Mature Arteries | Journal of Cardiovascular Pharmacology | 1993 | 252 |
27 | Grapes, Wines, Resveratrol, and Heart Health | Journal of Cardiovascular Pharmacology | 2009 | 247 |
28 | Evidence That Release of Adenosine Triphosphate From Endothelial Cells During Increased Shear Stress Is Vesicular | Journal of Cardiovascular Pharmacology | 2001 | 246 |
29 | Systemic Uric Acid Administration Increases Serum Antioxidant Capacity in Healthy Volunteers | Journal of Cardiovascular Pharmacology | 2001 | 246 |
30 | Migration of Endothelial Progenitor Cells Mediated by Stromal Cell-Derived Factor-1α/CXCR4 via PI3K/Akt/eNOS Signal Transduction Pathway | Journal of Cardiovascular Pharmacology | 2007 | 243 |
31 | Pharmacologic Profile of the Dihydropyrimidine Calcium Channel Blockers SQ 32,547 and SQ 32,946 | Journal of Cardiovascular Pharmacology | 1995 | 241 |
32 | QTU-Prolongation and Torsades de Pointes Induced by Putative Class III Antiarrhythmic Agents in the Rabbit | Journal of Cardiovascular Pharmacology | 1990 | 235 |
33 | Effects of Vascular Endothelial Growth Factor on Hemodynamics and Cardiac Performance | Journal of Cardiovascular Pharmacology | 1996 | 228 |
34 | Antihypertensive Therapy with MK 4211 | Journal of Cardiovascular Pharmacology | 1982 | 227 |
35 | Cardiotonic Activity of Milrinone, a New and Potent Cardiac Bipyridine, on the Normal and Failing Heart of Experimental Animals | Journal of Cardiovascular Pharmacology | 1983 | 223 |
36 | Efficacy and Safety of Treprostinil: An Epoprostenol Analog for Primary Pulmonary Hypertension | Journal of Cardiovascular Pharmacology | 2003 | 219 |
37 | Acute Amelioration of Diabetic Endothelial Dysfunction with a Derivative of the Nitric Oxide Synthase Cofactor, Tetrahydrobiopterin | Journal of Cardiovascular Pharmacology | 1997 | 216 |
38 | A Novel Pharmacologic Inhibitor of the NLRP3 Inflammasome Limits Myocardial Injury After Ischemia–Reperfusion in the Mouse | Journal of Cardiovascular Pharmacology | 2014 | 215 |
39 | Nitric Oxide (NO) Donor Molecules | Journal of Cardiovascular Pharmacology | 1995 | 213 |
40 | Stereoselectivity at the Calcium Channel | Journal of Cardiovascular Pharmacology | 1985 | 211 |
41 | Cardiovascular Response to 8-Hydroxy-2-(di-n-Propylamino) Tetralin (8-OH-DPAT) in the Rat: Site of Action and Pharmacological Analysis | Journal of Cardiovascular Pharmacology | 1987 | 208 |
42 | Troponin C–Mediated Calcium Sensitization Induced by Levosimendan Does Not Impair Relaxation | Journal of Cardiovascular Pharmacology | 1995 | 207 |
43 | Curcumin Lowers Serum Lipids and Uric Acid in Subjects With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial | Journal of Cardiovascular Pharmacology | 2016 | 206 |
44 | Cardiovascular Effects of Serotonin Agonists and Antagonists | Journal of Cardiovascular Pharmacology | 1990 | 203 |
45 | Tetrahydrobiopterin Improves Endothelial Function in Patients with Coronary Artery Disease | Journal of Cardiovascular Pharmacology | 2000 | 201 |
46 | Antagonism by Ranolazine of the Pro-Arrhythmic Effects of Increasing Late INa in Guinea Pig Ventricular Myocytes | Journal of Cardiovascular Pharmacology | 2004 | 199 |
47 | Endothelium-Removal Decreases Relaxations of Canine Coronary Arteries Caused by β-Adrenergic Agonists and Adenosine | Journal of Cardiovascular Pharmacology | 1985 | 196 |
48 | Cannabinoids Acting on CB1 Receptors Decrease Contractile Performance in Human Atrial Muscle | Journal of Cardiovascular Pharmacology | 2003 | 195 |
49 | Amino Acid 49 Polymorphisms of the Human β 1 -Adrenergic Receptor Affect Agonist-Promoted Trafficking | Journal of Cardiovascular Pharmacology | 2002 | 194 |
50 | Sympathetic Nervous System Activation in Essential Hypertension, Cardiac Failure and Psychosomatic Heart Disease | Journal of Cardiovascular Pharmacology | 2000 | 193 |